Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90294046 | 9029404 | 6 | F | 20110612 | 20160727 | 20130125 | 20160803 | EXP | DK-DKMA-ADR 21987236 | DK-BRISTOL-MYERS SQUIBB COMPANY-17297516 | BRISTOL MYERS SQUIBB | 10.77 | YR | M | Y | 56.00000 | KG | 20160803 | CN | DE | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90294046 | 9029404 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 5 MG, QD | 154.365006 | MG | Y | 21436 | 5 | MG | TABLET | QD | |||
| 90294046 | 9029404 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 1DF: 1 MG/ML | Y | 0 | 1 | DF | ORAL SOLUTION | ||||||
| 90294046 | 9029404 | 3 | C | MELATONIN | MELATONIN | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 90294046 | 9029404 | 1 | Tourette's disorder |
| 90294046 | 9029404 | 2 | Tourette's disorder |
| 90294046 | 9029404 | 3 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 90294046 | 9029404 | DS |
| 90294046 | 9029404 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 90294046 | 9029404 | Akathisia | |
| 90294046 | 9029404 | Apathy | |
| 90294046 | 9029404 | Ataxia | |
| 90294046 | 9029404 | Cognitive disorder | |
| 90294046 | 9029404 | Disturbance in social behaviour | |
| 90294046 | 9029404 | Fatigue | |
| 90294046 | 9029404 | General physical health deterioration | |
| 90294046 | 9029404 | Hallucination | |
| 90294046 | 9029404 | Learning disability | |
| 90294046 | 9029404 | Memory impairment | |
| 90294046 | 9029404 | Motor dysfunction | |
| 90294046 | 9029404 | Off label use | |
| 90294046 | 9029404 | Petit mal epilepsy | |
| 90294046 | 9029404 | Suicide attempt | |
| 90294046 | 9029404 | Tic | |
| 90294046 | 9029404 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 90294046 | 9029404 | 1 | 20110526 | 20121018 | 0 | |
| 90294046 | 9029404 | 2 | 20110526 | 20121018 | 0 | |
| 90294046 | 9029404 | 3 | 20120614 | 0 |